CRISPR/Cas9 Delivery Mediated with Hydroxyl‐Rich Nanosystems for Gene Editing in Aorta

A CRISPR/Cas9 system has emerged as a powerful tool for gene editing to treat genetic mutation related diseases. Due to the complete endothelial barrier, effective delivery of the CRISPR/Cas9 system to vasculatures remains a challenge for in vivo gene editing of genetic vascular diseases especially...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaoping, Xu, Chen, Gao, Shijuan, Li, Ping, Kong, Yu, Li, Tiantian, Li, Yulin, Xu, Fu‐Jian, Du, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662060/
https://www.ncbi.nlm.nih.gov/pubmed/31380173
http://dx.doi.org/10.1002/advs.201900386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662060/
https://www.ncbi.nlm.nih.gov/pubmed/31380173
http://dx.doi.org/10.1002/advs.201900386

Ejemplares similares